Cargando…

Diagnostic and Predictive Values of (18)F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma

PURPOSE: The clinical implications of the metabolic parameters of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET/CT) in epidermal growth factor receptor (EGFR)-mutated lung cancer are not fully understood. The aim of this study was to evaluate the diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Il Ki, Lee, Jeong Mi, Hwang, In Kyoung, Paik, Seung Sook, Kim, Chanwoo, Lee, Seung Hyeun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396957/ https://www.ncbi.nlm.nih.gov/pubmed/32801885 http://dx.doi.org/10.2147/CMAR.S259055

Ejemplares similares

Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
por: Hwang, In Kyoung, et al.
Publicado: (2019)

Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis
por: Paik, Seung Sook, et al.
Publicado: (2018)

Clinical correlation of metabolic parameters on (18)F-FDG PET/CT in idiopathic frozen shoulder
por: Won, Kyoung Sook, et al.
Publicado: (2017)

The predictive value of (18)F-FDG PET/CT in an EGFR-mutated lung adenocarcinoma population
por: Wang, Jian, et al.
Publicado: (2022)

Correlation of EGFR or KRAS mutation status with (18)F-FDG uptake on PET-CT scan in lung adenocarcinoma
por: Takamochi, Kazuya, et al.
Publicado: (2017)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

Prognostic Value of Baseline (18)F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status
por: Wang, Dalong, et al.
Publicado: (2016)

Diagnostic value of (18)F-FDG PET/CT in discriminating between benign and malignant lesions of the ribs
por: Choi, Sunju, et al.
Publicado: (2022)

Delayed (18)F-FDG PET/CT Appearance of Urachal Adenocarcinomas
por: Xu, Lian, et al.
Publicado: (2020)

Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
por: Yoon, Ja Kyung, et al.
Publicado: (2022)

Prognostic significance of preoperative (18)F-FDG PET/CT in uterine leiomyosarcoma
por: Park, Jeong-Yeol, et al.
Publicado: (2017)

The Prognostic Value of (18)F-FDG PET/CT Metabolic Parameters in Predicting Treatment Response Before EGFR TKI Treatment in Patients with Advanced Lung Adenocarcinoma
por: Agüloğlu, Nurşin, et al.
Publicado: (2022)

Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by (18)F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer
por: Song, Bong-Il, et al.
Publicado: (2015)

Prognostic value of (18)F-FDG PET/CT metabolic parameters in small cell lung cancer
por: Choi, Eun Kyoung, et al.
Publicado: (2019)

Prognostic Significance of Metabolic Parameters by (18)F-FDG PET/CT in Thymic Epithelial Tumors
por: Lee, Joohee, et al.
Publicado: (2021)

Predictive Value of [(18)F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
por: Kim, Sung Hoon, et al.
Publicado: (2019)

Prognostic value of the metabolic score obtained via [(18)F]FDG PET/CT and a new prognostic staging system for gastric cancer
por: Kim, Sung Hoon, et al.
Publicado: (2022)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Association Analysis of Maximum Standardized Uptake Values Based on (18)F-FDG PET/CT and EGFR Mutation Status in Lung Adenocarcinoma
por: Gao, Jianxiong, et al.
Publicado: (2023)

Predictive value of metabolic activity detected by pre-operative (18)F FDG PET/CT in ampullary adenocarcinoma
por: Park, Young Mok, et al.
Publicado: (2021)

Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022)

18F-FDG PET/CT Imaging of Gallbladder Adenocarcinoma - A Pictorial Review
por: Shaikh, Faiq, et al.
Publicado: (2015)

Mesonephric Adenocarcinoma of the Uterine Fundus Exhibiting High (18)F-FDG Uptake
por: Kim, Hyung Kyung, et al.
Publicado: (2020)

Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for Localizing Recurrence in Patients with Differentiated Thyroid Carcinoma
por: Lee, Jandee, et al.
Publicado: (2012)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

(18)F-FDG PET Metabolic Parameters and MRI Perfusion and Diffusion Parameters in Hepatocellular Carcinoma: A Preliminary Study
por: Ahn, Sung Jun, et al.
Publicado: (2013)

(18)F-FDG PET/CT Parameters Enhance MRI Radiomics for Predicting Human Papilloma Virus Status in Oropharyngeal Squamous Cell Carcinoma
por: Jo, Kwan Hyeong, et al.
Publicado: (2023)

[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
por: Nappi, Antonio, et al.
Publicado: (2015)

Prediction of EGFR Mutation Status Based on (18)F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma
por: Yin, Guotao, et al.
Publicado: (2021)

Diagnostic accuracy of (18)F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer
por: Choi, Byung Wook, et al.
Publicado: (2016)

Prognostic Value of (18)F-FDG PET/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients
por: Tosi, Davide, et al.
Publicado: (2021)

Comparison of CT and (18)F-FDG PET for Detecting Peritoneal Metastasis on the Preoperative Evaluation for Gastric Carcinoma
por: Lim, Joon Seok, et al.
Publicado: (2006)

Prognostic Impact of Total Lesion Glycolysis (TLG) from Preoperative (18)F-FDG PET/CT in Stage II/III Colorectal Adenocarcinoma: Extending the Value of PET/CT for Resectable Disease
por: Lee, Sea-Won, et al.
Publicado: (2022)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

Metabolic parameters on baseline (18)F-FDG PET/CT are potential predictive biomarkers for immunotherapy in patients with head and neck squamous cell carcinoma
por: Kwon, Hye Ryeong, et al.
Publicado: (2022)

Candida Esophagitis Incidentally Detected by 18F-FDG PET/CT in Metastatic Lung Adenocarcinoma
por: Martínez-Amador, N, et al.
Publicado: (2017)

PD-L1 in Lung Adenocarcinoma: Insights into the Role of (18)F-FDG PET/CT
por: Cui, Yan, et al.
Publicado: (2020)

Parotid gland metastasis of lung adenocarcinoma identified on surveillance (18)F-FDG PET/CT
por: Soputro, Nicolas Adrianto, et al.
Publicado: (2022)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ija9ffcslrk5129hq17bjcrlf4